The 22 references in paper O. Simbirtseva F., E. Khitrinskaya Yu., I. Ivanchuk I., V. Kalyuzhin V., L. Zibnitskaya I., L. Tkalich M., E. Kalyuzhina V., О. Сибирева Ф., Е. Хитринская Ю., И. Иванчук И., В. Калюжин В., Л. Зибницкая И., Л. Ткалич М., Е. Калюжина В. (2008) “ГЕНЕТИЧЕСКАЯ ДЕТЕРМИНИРОВАННОСТЬ ПОВЫШЕНИЯ ТРОМБОГЕННОГО ПОТЕНЦИАЛА КРОВИ У БОЛЬНЫХ ХРОНИЧЕСКИМ ГЛОМЕРУЛОНЕФРИТОМ // GENETICALY DETERMINED ELEVATION OF THROMBOGENIC POTENTIAL OF BLOOD IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS” / spz:neicon:nefr:y:2008:i:2:p:52-55

1
Тареева ИЕ, Мухин НА. Механизмы прогрессирова­ ния нефрита. В: Тареева ИЕ, ред. Нефрология: руководство для врачей. Том. 2. Медицина, М., 2000; 20-28
(check this in PDF content)
2
Рябов СИ. Нефрология: руководство для врачей. СпецЛит, СПб., 2000; 672
(check this in PDF content)
3
Шулутко БИ. Нефрология 2002. Современное состоя­ ние проблемы. Ренкор, СПб., 2002; 780
(check this in PDF content)
4
Глессок РД, Бреннер БМ. Иммунопатогенетические механизмы повреждения почек. В: Браунвальд Е, Иссель- бахер КДж, Петерсдорф РГ, ред. Внутренние болезни. Кни­ га. 6. Медицина, М., 1995; 282-289
(check this in PDF content)
5
Спиридонова МГ, Степанов ВА, Пузырев ВП. О роли полиморфных вариантов гена 5,10-метилентетрагидрофо- латредуктазы (MTHFR) в патогенезе сердечно-сосудистых заболеваний. Клин мед 2001; (2): 10-16
(check this in PDF content)
6
Rosenberg N, Murata M, Ikeda Y et al. The Frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, japanese, and africans. Am J Hum Genet 2002; 71: 758-762
(check this in PDF content)
7
Добронравов ВА, Голубев РВ. Гипергомоцистеине- мия - фактор риска сердечно-сосудистых поражений у ди­ ализных больных и в общей популяции. Нефрология 2004; (2): 44-49
(check this in PDF content)
8
Fodinger M, Mannhalter C, Wolfl G et al. Mutation (677 С to T) in the methyltetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients. Kidney Int 1997; 52: 517-523
(check this in PDF content)
9
Момот АП. Патология гемостаза. Принципы и алго­ ритмы клинико-лабораторной диагностики. Форма Т, СПб., 2006; 208
(check this in PDF content)
10
Насонов ЕЛ. Антифосфолипидный синдром. Лит- терра, М., 2004; 440
(check this in PDF content)
11
Irish A. The factor V Leiden mutation and risk of renal vein thrombosis in patients with nephrotic syndrome. Nephrol Dial Transplant 1997; 12: 1680-1683
(check this in PDF content)
12
Aucella F, Margaglione M, Grandone E et al. On behalf of The Genetic Polymorphisms in Dialysis Study Group. The C677T methylenetetrahydrofolate reductase gene mutation does not influence cardiovascular risk in the dialysis population: results of a multicentre prospective study. Nephrol Dial Transplant 2004; 20 (2): 382-386
(check this in PDF content)
13
Haviv YS, Shpichinetsky V, Goldschmidt N et al. The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients. Nephron 2002; 92: 120-126
(check this in PDF content)
14
Morimoto K, Haneda T, Okamoto K et al. Methylenetetrahydrofolate reductase gene polymorphism, hyperhomocysteinemia, and cardiovascular diseases in chronic hemodialysis patients. Nephron 2002; 90: 43-50
(check this in PDF content)
15
Quintana LF, Cofan F, Reverte JC et al. Renal cortical necrosis after kidney transplantation associated with the prothrombin 20210A mutation. Nephrol Dial Transplant 2006; 21 (5): 1455-1456
(check this in PDF content)
16
Irish A. Hypercoagulability in renal transplant recipients. Identifying patients at risk of renal allograft thrombosis and evaluating strategies for prevention. Am J Cardiovasc Drugs 2004; 4: 139-149
(check this in PDF content)
17
Heidenreich S, Junker R, Wolters H et al. Outcome of kidney transplantation in patients with inherited thrombophilia: data of a prospective study. J Am Soc Nephrol 2003; 14: 234­ 239
(check this in PDF content)
18
Heidenreich S, Junker R, Wolters H. Outcome of kidney transplantation in patients with inherited thrombophilia: data of a prospective study. J Am Soc Nephrol 2003; 14 (1): 234-239
(check this in PDF content)
19
Zychma MJ, Gumprecht J, Grzeszczak W, Zukowska- Szczechowska E. Methylenetetrahydrofolate reductase gene C677T polymorphism, plasma homocysteine and folate in end- stage renal disease dialysis and non-dialysis patients. Nephron
(check this in PDF content)
20
2; 92: 235-239 20. Winkelmayer WC, Kramar R, Sunder-Plassmann G, Fцdinger M. Effects of single-nucleotide polymorphisms in MTHFR and MTRR on mortality and allograft loss in kidney transplant recipients. Kidney Int 2005; 68: 2857-2862
(check this in PDF content)
21
Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 2003; 146: 948-957
(check this in PDF content)
22
Kabukcu S. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of denizli. Clinical and Applied Thrombosis/Hemostasis 2007; 13 (2): 166-171
(check this in PDF content)